New drug target for triple-negative breast cancer
Research reports a combination of a novel small inhibitory molecule and an FDA-approved chemotherapy drug suppresses the growth of triple-negative breast cancer cells synergistically.
Materials provided by Louisiana State University Health Sciences Center. Note: Content may be edited for style and length.
Source link aaaaa